Q2 FY2026 EarningsQ2 FY2026 results were in-line on revenue ($31.9M vs. $31.9M expected) but significantly beat on profitability: GAAP net income was $1.1M vs. $0.7M consensus, and Adjusted EPS of $0.06 beat the $0.02 mean estimate. The 16% YoY revenue growth was supported by AI solution adoption and the acquisition of Empower Healthcare. Despite a 23% YoY decline in Adjusted EBITDA to $5.9M due to increased R&D and interest costs from Series B preferred stock redemption, management reaffirmed FY2026 guidance, signaling confidence in long-term margin expansion.